FEDERAL
Cybersecurity
Testimony by Adam Bruggeman, MD, to the U.S. House Energy and Commerce Committee Regarding Health Sector Cybersecurity After Change Healthcare Attack (April 16, 2024)
Health Information Technology
TMA Comment Letter to the Assistant Secretary for Technology Policy on Health Data, Technology, and Interoperability proposed regulations (Oct. 1, 2024)
TMA Comment Letter to the Agency for Healthcare Research and Quality Re: CDS Connect RFI posted to the Federal Register (July 23, 2024)
TMA Comment Letter to the Office of the National Coordinator Re: United States Core Data for Interoperability Draft Version 5 (April 8, 2024)
Payment
Comment Letter From Medical Societies Urgently Requesting Congressional Leaders to Pass Legislation to Both Prevent the Scheduled 2.83 Percent Medicare Physician Payment Cut and, Provide a Positive Payment Update for 2025 (Nov 15, 2024)
TMA Comment Letter to CMS on the Proposed 2025 Medicare Physician Fee Schedule (Sep. 6, 2024)
Comment Letter From Medical Societies urging Congress to prioritize and advance several key bills and legislative proposals that provide greater fiscal stability for physicians and reform key elements of the Medicare Access and CHIP Reauthorization Act (MACRA). (July 24, 2024)
TMA Comment Letter to the Ways and Means Committee Regarding the Collapse of Independent Payment Practice (June 6, 2024)
TMA Letter to Senators Cornyn for a Senate Finance Hearing on Chronic Care/Medicare Physician Payments (April 11, 2024)
TMA Letter to Senators Cornyn and Cruz calling for a reverse to the 2024 Medicare Physician Payment Cut (Feb. 22, 2024)
Comment Letter From Medical Societies: Strongly Urging Congress to Quickly Pass Legislation to Reverse the 3.37 Percent Medicare Physician Payment Cuts That Took Effect On Jan. 1, 2024 (Jan. 17, 2024)
Scope
Comment Letter From Medical Societies to Congress opposing bills that would inappropriately allow pharmacists to perform services that would otherwise be covered if they had been furnished by a physician, test and treat patients for certain illnesses and expand Medicare payment for pharmacists in limited but significant ways (July 23, 2024)
Surprise Billing
TMA Comment Letter by President Rick W. Snyder II, MD, to the U.S. House Ways and Means Committee regarding Access to Health Care in America: Ensuring Resilient Emergency Medical Care (March 18, 2024)
TMA Letter to Federal Agencies Regarding No Surprises Act Independent Dispute Resolution Proposed Rule, (Jan. 2, 2024)
TMA Comment Letter to U.S. Department of Health and Human Services: Re: RIN 0938-AV15 (Federal Independent Dispute Resolution Operations Proposed Rule) (Jan. 2, 2024)
STATE
Abortion
TMA Supplemental Comments Regarding Texas Medical Board Proposed Rules on Medical Exceptions Relating to Abortions (June 17, 2024)
TMA Comments Regarding Texas Medical Board Proposed Rules on Medical Exceptions Relating to Abortions (May 4, 2024)
Graduate Medical Education / Workforce
TMA Comment Letter to the Texas Higher Education Coordinating Board Regarding Rural Resident Physician Grant Program (June 25, 2024)
Health Information Technology
TMA Comment Letter to State Rep. Giovanni Capriglione Re: Artificial Intelligence Regulation | AI Stakeholder Feedback (March 8, 2024)
Insurance
TMA Comment Letter to Texas Department of Insurance Regarding Multiple Employer Welfare Arrangements (June 3, 2024)
TMA and Association Comment Letter to Texas Department of Insurance RE: PPO and EPO Rule Proposal (Jan. 22, 2024)
Medicaid
TMA, Stakeholders Seek Texas HHS Fixes for Medicaid Physician/Provider Enrollment System (Comment Letter to the Texas Health and Human Services Commission Regarding Medicaid PEMS, Nov. 1, 2024)
TMA Comment Letter to the Texas Health and Human Services Commission OIG Regarding Proposed Rule #23R031, Recoupment of Overpayments Identified by Inspection (July 15, 2024).
Payment
TMA, TSA, TxSCO Letter to HHSC in Response to Proposed Medicaid Payment Rates for the Medicaid Biennial Calendar Fee Review (Nov 12, 2024)
Public Health
TMA Offers Improvements to Law Prohibiting Employers From Imposing Coronavirus Vaccine Mandates (TMA Comment Letter by President G. Ray Callas, MD, to the Texas Workforce Commission Regarding Rules RE: Prohibited COVID-19 Vaccine Mandates by Private Employers, Nov. 4, 2024.)
Texas Tobacco Control Coalition Letter to the Legislative Budget Board Supporting DSHS Tobacco-Related Budget Recommendations (Oct. 3, 2024)
Texas Women's Healthcare Coalition Comments to Texas Legislative Budget Board on 2026-27 Funding for Women's Health Programs (Sept. 30, 2024)
TMA Written Comments Seeks Community Voice on MMMRC, Data-Sharing with CDC (TMA Written Comments to Texas Maternal Mortality and Morbidity Review Committee, Sept. 27, 2024)
TMA Comment Letter to the Texas Department of State Health Services Re: Proposed Revisions to the State’s Emergency Medical System and Trauma Care Rules (Sept. 3, 2024)
TMA Comment Letter to the Texas Department of State Health Services Concerning Proposed Rule #23R011, Regarding Radiation Control (July 15, 2024).
TMA and TPS Comments to HHSC Regarding Draft Rule 24R058 (HB 44) (June 25, 2024)
TMA Comment Letter to the Texas Health and Human Services Commission Regarding State Hospital Essential Caregiver Designation (June 3, 2024)
TMA Comment Letter to Texas Department of State Health Services RE: Proposed Trauma Designation Rules 21R151 (Feb. 16, 2024)
Scope of Practice
TMA Comment Letter to TDLR Regarding Podiatric Medicine Professional Identifiers, Designations, (July 21, 2024)
TMA Comment Letter to Texas Health and Human Services RE: Proposed Rule 22R054 (Jan. 22, 2024)
TMA Comment Letter to Texas Board of Nursing RE: SB 1343 Implementation (Jan. 21, 2024)